News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orexigen (OREX) Announces Second Quarter 2017 Financial Results



8/9/2017 12:17:16 PM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
SAN DIEGO, Aug. 8, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the second quarter ended June 30, 2017.

"Our performance in the second quarter of 2017 reflects the successful implementation of our commercial strategy that we launched late last year. The team at Orexigen has delivered dramatic growth of U.S. Contrave sales in the first half of 2017," said Mike Narachi, President and Chief Executive Officer of Orexigen.

Read at PR Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES